Abstract
Summary
LPI (LP Information)' newest research report, the “Veterinary DNA Vaccines Industry Forecast” looks at past sales and reviews total world Veterinary DNA Vaccines sales in 2022, providing a comprehensive analysis by region and market sector of projected Veterinary DNA Vaccines sales for 2023 through 2029. With Veterinary DNA Vaccines sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Veterinary DNA Vaccines industry.
This Insight Report provides a comprehensive analysis of the global Veterinary DNA Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary DNA Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Veterinary DNA Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary DNA Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary DNA Vaccines.
The global Veterinary DNA Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Veterinary DNA Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Veterinary DNA Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Veterinary DNA Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Veterinary DNA Vaccines players cover Zoetis, Inc., Ceva Santé Animale, Boehringer Ingelheim and MSD Animal Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary DNA Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Poultry
Ruminants
Feline
Canine
Segmentation by application
Veterinary Hospital
Laboratory
CROs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis, Inc.
Ceva Santé Animale
Boehringer Ingelheim
MSD Animal Health
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary DNA Vaccines market?
What factors are driving Veterinary DNA Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary DNA Vaccines market opportunities vary by end market size?
How does Veterinary DNA Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
This Insight Report provides a comprehensive analysis of the global Veterinary DNA Vaccines landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Veterinary DNA Vaccines portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Veterinary DNA Vaccines market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Veterinary DNA Vaccines and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Veterinary DNA Vaccines.
The global Veterinary DNA Vaccines market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Veterinary DNA Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Veterinary DNA Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Veterinary DNA Vaccines is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Veterinary DNA Vaccines players cover Zoetis, Inc., Ceva Santé Animale, Boehringer Ingelheim and MSD Animal Health, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Veterinary DNA Vaccines market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Poultry
Ruminants
Feline
Canine
Segmentation by application
Veterinary Hospital
Laboratory
CROs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Zoetis, Inc.
Ceva Santé Animale
Boehringer Ingelheim
MSD Animal Health
Key Questions Addressed in this Report
What is the 10-year outlook for the global Veterinary DNA Vaccines market?
What factors are driving Veterinary DNA Vaccines market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Veterinary DNA Vaccines market opportunities vary by end market size?
How does Veterinary DNA Vaccines break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Veterinary DNA Vaccines Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Veterinary DNA Vaccines by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Veterinary DNA Vaccines by Country/Region, 2018, 2022 & 2029
2.2 Veterinary DNA Vaccines Segment by Type
2.2.1 Poultry
2.2.2 Ruminants
2.2.3 Feline
2.2.4 Canine
2.3 Veterinary DNA Vaccines Sales by Type
2.3.1 Global Veterinary DNA Vaccines Sales Market Share by Type (2018-2023)
2.3.2 Global Veterinary DNA Vaccines Revenue and Market Share by Type (2018-2023)
2.3.3 Global Veterinary DNA Vaccines Sale Price by Type (2018-2023)
2.4 Veterinary DNA Vaccines Segment by Application
2.4.1 Veterinary Hospital
2.4.2 Laboratory
2.4.3 CROs
2.4.4 Others
2.5 Veterinary DNA Vaccines Sales by Application
2.5.1 Global Veterinary DNA Vaccines Sale Market Share by Application (2018-2023)
2.5.2 Global Veterinary DNA Vaccines Revenue and Market Share by Application (2018-2023)
2.5.3 Global Veterinary DNA Vaccines Sale Price by Application (2018-2023)
3 Global Veterinary DNA Vaccines by Company
3.1 Global Veterinary DNA Vaccines Breakdown Data by Company
3.1.1 Global Veterinary DNA Vaccines Annual Sales by Company (2018-2023)
3.1.2 Global Veterinary DNA Vaccines Sales Market Share by Company (2018-2023)
3.2 Global Veterinary DNA Vaccines Annual Revenue by Company (2018-2023)
3.2.1 Global Veterinary DNA Vaccines Revenue by Company (2018-2023)
3.2.2 Global Veterinary DNA Vaccines Revenue Market Share by Company (2018-2023)
3.3 Global Veterinary DNA Vaccines Sale Price by Company
3.4 Key Manufacturers Veterinary DNA Vaccines Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Veterinary DNA Vaccines Product Location Distribution
3.4.2 Players Veterinary DNA Vaccines Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Veterinary DNA Vaccines by Geographic Region
4.1 World Historic Veterinary DNA Vaccines Market Size by Geographic Region (2018-2023)
4.1.1 Global Veterinary DNA Vaccines Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Veterinary DNA Vaccines Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Veterinary DNA Vaccines Market Size by Country/Region (2018-2023)
4.2.1 Global Veterinary DNA Vaccines Annual Sales by Country/Region (2018-2023)
4.2.2 Global Veterinary DNA Vaccines Annual Revenue by Country/Region (2018-2023)
4.3 Americas Veterinary DNA Vaccines Sales Growth
4.4 APAC Veterinary DNA Vaccines Sales Growth
4.5 Europe Veterinary DNA Vaccines Sales Growth
4.6 Middle East & Africa Veterinary DNA Vaccines Sales Growth
5 Americas
5.1 Americas Veterinary DNA Vaccines Sales by Country
5.1.1 Americas Veterinary DNA Vaccines Sales by Country (2018-2023)
5.1.2 Americas Veterinary DNA Vaccines Revenue by Country (2018-2023)
5.2 Americas Veterinary DNA Vaccines Sales by Type
5.3 Americas Veterinary DNA Vaccines Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Veterinary DNA Vaccines Sales by Region
6.1.1 APAC Veterinary DNA Vaccines Sales by Region (2018-2023)
6.1.2 APAC Veterinary DNA Vaccines Revenue by Region (2018-2023)
6.2 APAC Veterinary DNA Vaccines Sales by Type
6.3 APAC Veterinary DNA Vaccines Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Veterinary DNA Vaccines by Country
7.1.1 Europe Veterinary DNA Vaccines Sales by Country (2018-2023)
7.1.2 Europe Veterinary DNA Vaccines Revenue by Country (2018-2023)
7.2 Europe Veterinary DNA Vaccines Sales by Type
7.3 Europe Veterinary DNA Vaccines Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Veterinary DNA Vaccines by Country
8.1.1 Middle East & Africa Veterinary DNA Vaccines Sales by Country (2018-2023)
8.1.2 Middle East & Africa Veterinary DNA Vaccines Revenue by Country (2018-2023)
8.2 Middle East & Africa Veterinary DNA Vaccines Sales by Type
8.3 Middle East & Africa Veterinary DNA Vaccines Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Veterinary DNA Vaccines
10.3 Manufacturing Process Analysis of Veterinary DNA Vaccines
10.4 Industry Chain Structure of Veterinary DNA Vaccines
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Veterinary DNA Vaccines Distributors
11.3 Veterinary DNA Vaccines Customer
12 World Forecast Review for Veterinary DNA Vaccines by Geographic Region
12.1 Global Veterinary DNA Vaccines Market Size Forecast by Region
12.1.1 Global Veterinary DNA Vaccines Forecast by Region (2024-2029)
12.1.2 Global Veterinary DNA Vaccines Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Veterinary DNA Vaccines Forecast by Type
12.7 Global Veterinary DNA Vaccines Forecast by Application
13 Key Players Analysis
13.1 Zoetis, Inc.
13.1.1 Zoetis, Inc. Company Information
13.1.2 Zoetis, Inc. Veterinary DNA Vaccines Product Portfolios and Specifications
13.1.3 Zoetis, Inc. Veterinary DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Zoetis, Inc. Main Business Overview
13.1.5 Zoetis, Inc. Latest Developments
13.2 Ceva Santé Animale
13.2.1 Ceva Santé Animale Company Information
13.2.2 Ceva Santé Animale Veterinary DNA Vaccines Product Portfolios and Specifications
13.2.3 Ceva Santé Animale Veterinary DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Ceva Santé Animale Main Business Overview
13.2.5 Ceva Santé Animale Latest Developments
13.3 Boehringer Ingelheim
13.3.1 Boehringer Ingelheim Company Information
13.3.2 Boehringer Ingelheim Veterinary DNA Vaccines Product Portfolios and Specifications
13.3.3 Boehringer Ingelheim Veterinary DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Boehringer Ingelheim Main Business Overview
13.3.5 Boehringer Ingelheim Latest Developments
13.4 MSD Animal Health
13.4.1 MSD Animal Health Company Information
13.4.2 MSD Animal Health Veterinary DNA Vaccines Product Portfolios and Specifications
13.4.3 MSD Animal Health Veterinary DNA Vaccines Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 MSD Animal Health Main Business Overview
13.4.5 MSD Animal Health Latest Developments
14 Research Findings and Conclusion